Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
2.300
+0.080 (3.60%)
At close: Sep 2, 2025, 4:00 PM
2.280
-0.020 (-0.87%)
After-hours: Sep 2, 2025, 4:10 PM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $66.32 million as of September 2, 2025. Its market cap has increased by 26.49% in one year.
Market Cap
66.32M
Enterprise Value
54.28M
1-Year Change
26.49%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $66.32M, an increase of 0.87%. That is a compound annual growth rate of 0.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 64.01M | 5.78% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |